New York City, NY -- (SBWIRE) -- 12/27/2013 -- StockMarketIntel.com issues a special report on the following stocks: Shengkai Innovations Inc (OTCMKTS:VALV), China Finance Online Co. (ADR) (NASDAQ:JRJC), Alseres Pharmaceuticals, Inc. (OTCMKTS:ALSE), China CGame Inc (OTCMKTS:CCGM)
Shengkai Innovations Inc (OTCMKTS:VALV) gained 16.05%, trading on 21,919 shares, to end the trade at $0.290. The stock changed hands in a range of $0.21 to $0.29, bringing its market capitalization to about $4.99 million. If we look at its trading history of the past 52 weeks, the share price suffered a low of $0.20 and was moved to the maximum level of $1.34. Shengkai Innovations, Inc., together with its subsidiaries, designs, manufactures, and distributes ceramic valves for industrial use in the People?s Republic of China. The company provides ceramic valves in various categories, including gate, ball, back, adjustable, cut-off, and special valves.
Will VALV Continue To Move Higher? Find Out Here
China Finance Online Co. (ADR) (NASDAQ:JRJC) added15.55%, to complete the trading session at $4.98, with a total volume of 503,906 shares. The stock, on average, trades on a volume of 267,078 shares. It floated in a range of $4.31 to $5.00 during the last trading session, with a beta value of 1.28. Its market capitalization now moved to about $110.49 million. In the past 52 weeks, the share price has not declined below $1.08 and above $5.07. China Finance Online Co., Limited provides integrated financial information and services in the People?s Republic of China. Its financial information and services include news, data, analytics, investment advisory, and brokerage-related services.
Why Should Investors Buy JRJC After The Recent Gain? Just Go Here and Find Out
Alseres Pharmaceuticals, Inc. (OTCMKTS:ALSE) recorded a fall of -30.23% and was in a range of $0.03-$0.04 before closing at $0.0300. The stock completed the day with a total volume of 43,720 shares, versus an average volume of 19,656 shares. The share price hit its 52-week low of $0.02 and $0.15 was the best price. Alseres Pharmaceuticals, Inc., a development stage biotechnology company, focuses on the development of diagnostic products primarily for disorders in the central nervous system. Its clinical product candidate includes Altropane, which is based on the molecular imaging program focusing on the diagnosis of Parkinsonian syndromes (PS), including Parkinson?s disease (PD) and dementia with lewy bodies.
Is it the Right to Grab ALSE after the Recent Slump? Get Free Trend Analysis Here
China CGame Inc (OTCMKTS:CCGM) declined -28.57% yesterday, bringing its market capitalization around $1.00 million. The share price, after opening at $0.07, made a high of $0.12 and hovered above $0.05 to end the day at $0.0500. The total number of shares that changed hands during the session was 6,038 shares, as compared to average trading volume of 6,007 shares. China CGame, Inc., through its subsidiaries, engages in the design, engineering, fabrication, and installation of curtain wall systems, roofing systems, steel construction systems, eco-energy saving building conservation systems, and related products for public works and commercial real estate projects.
Will CCGM Reach the Bottom after Yesterday’s Correction? Find Out Here
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)